Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Steven M Larson

13PUBLICATIONS
50CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersRadiation therapyMolecular targetsInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

Sort by Publication Date:
|May 19, 2026
Establishment of <sup>68</sup>Ga-DOTA-Based Pretargeted Radioimmunodiagnosis.

|Dec 01, 2025
Automated Imaging as an Adjunct to Serum and Clinical Biomarkers: A New Validated Prediction Tool for Metastatic Castration-Resistant Prostate Cancer.

Michael J Morris, Jessica Flynn, Binsheng Zhao

|Sep 15, 2023
Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs.

Lisa Bodei, R Michael Tuttle, Ravinder K Grewal

|May 12, 2023
The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients.

Audrey Mauguen, Ravinder K Grewal, Finn Augensen

|Jan 06, 2023
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response.

Claire M Storey, Mohamed Altai, Mesude Bicak

|Mar 05, 2022
Treatment of Patients with Acute Myeloid Leukemia with the Targeted Alpha-Particle Nanogenerator Actinium-225-Lintuzumab.

Todd L Rosenblat, Michael R McDevitt, Jorge A Carrasquillo

Pageof 3

Frequent Collaborators

4 joint publications

Nai-Kong V Cheung

4 joint publications

Darren R Veach

2 joint publications

Daniel Thorek

2 joint publications

Katharina Lückerath

2 joint publications

Claire M Storey

2 joint publications

Hans Lilja

2 joint publications

Sebastien Monette

2 joint publications

Brian H Santich

2 joint publications

Sarah M Cheal

2 joint publications

Hong-Fen Guo

Frequent Collaborators

4 joint publications

Nai-Kong V Cheung

4 joint publications

Darren R Veach

2 joint publications

Daniel Thorek

2 joint publications

Katharina Lückerath